scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0039-6109(16)40984-9 |
P698 | PubMed publication ID | 959952 |
P2093 | author name string | Salzman EW | |
Coe NP | |||
P2860 | cites work | Platelet and fibrinogen consumption in man. | Q33465660 |
Significance of intravascular coagulation and fibrinolysis in acute hepatic failure | Q33466813 | ||
Defibrination after brain-tissue destruction: A serious complication of head injury | Q33466827 | ||
Microangiopathic Hemolytic Anemia | Q33467396 | ||
Vascular Lesions: Possible Pathogenetic Basis of the Generalized Shwartzman Reaction | Q33467570 | ||
Therapeutic implications of disseminated intravascular coagulation | Q33467915 | ||
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Primary Pulmonary Hypertension | Q33468572 | ||
Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia | Q68697272 | ||
Current ideas on the mechanism of platelet aggregation | Q69010040 | ||
Disseminated intravascular coagulation | Q69161528 | ||
Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol | Q69359640 | ||
Disseminated Intravascular Coagulation During Heparin Therapy | Q69370879 | ||
Hemodynamic and Pathological Findings in Experimental Fat Embolism | Q69729247 | ||
Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid | Q69984230 | ||
Letter: Antithrombin 3 after operation | Q70003551 | ||
A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts | Q70017524 | ||
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency | Q70025820 | ||
Chronic intravascular coagulation syndrome | Q70083365 | ||
Oral contraceptives and low antithrombin-3 activity | Q70124521 | ||
The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII | Q70378658 | ||
The Role of Platelets in the Contact Phase of Blood Coagulation | Q70446946 | ||
Intravascular platelet aggregation in the heart induced by norepinephrine. Microscopic studies | Q70480844 | ||
The Clinical Challenge of Disseminated Intravascular Coagulation | Q71520971 | ||
Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia | Q71661240 | ||
Changes in the Hemostatic Mechanism After Myocardial Infarction | Q71832838 | ||
Laboratory Diagnosis of Disseminated Intravascular Coagulation | Q72095687 | ||
Does intravascular coagulation occur in hemorrhagic shock in man? | Q72101201 | ||
Diagnosis and treatment of intravascular coagulation | Q72188866 | ||
Microthrombosis in injured and burned patients | Q72231705 | ||
Coagulation Factors and Defibrination Syndrome in Anaphylaxis | Q72240667 | ||
Pulmonary and Circulatory Effects of Fibrinopeptides | Q72307189 | ||
Effects of adrenaline on human blood platelets | Q72329516 | ||
Fibrinolysis vs disseminated intravascular coagulation | Q72401576 | ||
Thrombogenic properties of epsilon amino caproic acid | Q72768242 | ||
Activation of Trypsinogen and Plasminogen by Thrombin Preparations* | Q72908893 | ||
Methods for the evaluation of human fibrinolysis; studies with two combined technics | Q74804031 | ||
Morphology and enumeration of human blood platelets | Q75602485 | ||
The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies | Q78981048 | ||
Studies on the role of intravascular coagulation in irreversible hemorrhagic shock | Q79405260 | ||
Reduction of thrombus formation on dialyser membranes by aspirin and RA 233 | Q93730386 | ||
Kasabach-Merritt syndrome: coagulo--analytical observations. | Q33469157 | ||
Changes in the blood coagulation system associated with septicemia | Q33472504 | ||
Recognition and treatment of intravascular coagulation | Q33473890 | ||
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts) | Q34058913 | ||
Actions and Interactions of Antithrombin and Heparin | Q35148665 | ||
THE SHWARTZMAN REACTION: PATHOGENETIC MECHANISMS AND CLINICAL MANIFESTATIONS. | Q35498122 | ||
An effect of antigen-antibody interaction on blood coagulation | Q36264082 | ||
The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces | Q36268965 | ||
Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro | Q36269052 | ||
Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit | Q37097524 | ||
Shwartzman reaction after human renal homotransplantation | Q37396491 | ||
New rapid method for diagnosis of deep venous thrombosis | Q39334443 | ||
Disseminated intravascular coagulation (DIC): An approach | Q39915056 | ||
Mechanisms and frequency of thrombosis in the coronary circulation | Q39943668 | ||
Platelet physiology and abnormalities of platelet function (first of two parts). | Q39944486 | ||
Aggregation of platelets by collagen | Q40350809 | ||
Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin | Q41216691 | ||
Excess intravascular coagulation complicating low cardiac output | Q41238758 | ||
A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis | Q43250371 | ||
In vivo platelet function in acute myocardial infarction, acute cerbrovascular accidents and following surgery | Q43476195 | ||
Sudden coronary death: The occurrence of platelet aggregates in the epicardial arteries of man | Q43519424 | ||
Heparin therapy in septicemia with disseminated intravascular coagulation | Q44264631 | ||
Disseminated intravascular coagulation associated with massive brain injury | Q44545125 | ||
Trauma and disseminated intravascular coagulation | Q44809449 | ||
Postoperative antithrombin-3 concentration | Q44914185 | ||
Platelets and Initiation of Intrinsic Clotting | Q45856269 | ||
Letter: Defibrination after head trauma | Q47840125 | ||
The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen-fibrin degradation products and fibrin monomer | Q47949396 | ||
Alterations in coagulation and fibrinolytic mechanisms in acute trauma | Q48967032 | ||
Fibrin Degradation Products in Normal and Abnormal Pregnancy and Parturition | Q49197367 | ||
Red-blood-cell fragmentation in microangiopathic haemolytic anaemia: in-vitro studies. | Q51202471 | ||
Editorial: Viruses and arteriosclerosis. | Q53741712 | ||
Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies. | Q54357825 | ||
Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin | Q54433531 | ||
New Vasoconstrictor, Bovine Peptide B, released during Blood Coagulation | Q59095989 | ||
The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis | Q59485564 | ||
POSTOPERATIVE ANTITHROMBIN III | Q59698271 | ||
Inherited Antithrombin Deficiency Causing Thrombophilia | Q64386294 | ||
Effect of smoking on blood coagulation and platelet survival in man. | Q64982879 | ||
The effect of major surgery, low doses of heparin and thromboembolism on plasma antithrombin. Comparison of immediate thrombin inhibiting capacity and the antithrombin III content | Q66892512 | ||
Management of heparin therapy: Controlled prospective trial | Q66893951 | ||
Homocystinemia. Vascular injury and arterial thrombosis | Q68342307 | ||
Activation of plasminogen by human plasma kallikrein | Q68435579 | ||
Platelet function in hyperlipoproteinemia | Q68676427 | ||
P433 | issue | 4 | |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 875-890 | |
P577 | publication date | 1976-08-01 | |
P1433 | published in | Surgical Clinics of North America | Q15765820 |
P1476 | title | Thrombosis and intravascular coagulation | |
P478 | volume | 56 |
Search more.